Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Mar 22 2000
WASHINGTON, DC (March 22, 2000) People benefiting from innovative biotechnology treatments against such diseases as rheumatoid arthritis, multiple sclerosis...
Mar 17 2000
WASHINGTON, D.C. (March 17, 2000) Featured speakers at BIO 2000's lunch Wednesday, March 29, will discuss a variety of topics, including the risks and...
Mar 16 2000
WASHINGTON, DC (March 15, 2000) In response to the statement March 14 by President Bill Clinton and British Prime Minister Tony Blair and subsequent reaction...
Mar 14 2000
Washington, D.C., (March 14, 2000) -- BIO 2000 in Boston, March 26-30, will include the largest international contingent ever assembled for the annual...
Mar 14 2000
WASHINGTON, DC (March 14, 2000) The Biotechnology Industry Organization (BIO) issued the following response to the statement made today by President Bill...
Mar 10 2000
WASHINGTON, D.C. (March 10, 2000) The Biotechnology Industry Organization (BIO) applauded the National Institutes of Health Recombinant DNA Advisory Committee...
Mar 8 2000
WASHINGTON, D.C. (March 8, 2000) Nancy Myers, health care policy and reimbursement counsel of the Biotechnology Industry Organization (BIO), issued the...
Mar 7 2000
WASHINGTON, D.C. (March 7, 2000) BIO 2000 in Boston, March 26-30, will feature four days of scientific presentations examining the latest research on a...
Mar 7 2000
(Dr. Val Giddings, vice president for food and agriculture for BIO, today issued the following statement regarding USDA’s proposed new national organic...